Fertility and Sterility
Volume 93, Issue 1 , Pages 319-321 , 1 January 2010

Similar ongoing pregnancy rates after blastocyst transfer in fresh donor cycles and autologous cycles using cryopreserved bipronuclear oocytes suggest similar viability of transferred blastocysts

  • Bruce S. Shapiro, M.D., Ph.D.

      Affiliations

    • Fertility Center of Las Vegas, University of Nevada School of Medicine, Las Vegas, Nevada
    • Department of Obstetrics and Gynecology, University of Nevada School of Medicine, Las Vegas, Nevada
    • Corresponding Author InformationReprint requests: Bruce Shapiro M.D., Fertility Center of Las Vegas, 8851 West Sahara Avenue, Las Vegas, Nevada 89117 (FAX: 702-254-1213).
    • ,
  • Said T. Daneshmand, M.D.

      Affiliations

    • Fertility Center of Las Vegas, University of Nevada School of Medicine, Las Vegas, Nevada
    • Department of Obstetrics and Gynecology, University of Nevada School of Medicine, Las Vegas, Nevada
    • ,
  • Forest C. Garner, M.Sc.

      Affiliations

    • Fertility Center of Las Vegas, University of Nevada School of Medicine, Las Vegas, Nevada
    • Department of Obstetrics and Gynecology, University of Nevada School of Medicine, Las Vegas, Nevada
    • ,
  • Martha Aguirre, Ph.D.

      Affiliations

    • Fertility Center of Las Vegas, University of Nevada School of Medicine, Las Vegas, Nevada
    • ,
  • Cynthia Hudson, M.S.

      Affiliations

    • Fertility Center of Las Vegas, University of Nevada School of Medicine, Las Vegas, Nevada
    • ,
  • Shyni Thomas, B.Sc.

      Affiliations

    • Fertility Center of Las Vegas, University of Nevada School of Medicine, Las Vegas, Nevada

Received 16 March 2009 ,Revised 5 June 2009 ,Accepted 2 July 2009.

References 

  1. Society for Assisted Reproductive Technology. IVF success rate reports: 2007. www.SART.org.
  2. Check JH, Choe JK, Katsoff D, Summers-Chase D, Wilson C. Controlled ovarian hyperstimulation adversely affects implantation following in vitro fertilization-embryo transfer. J Assist Reprod Genet. 1999;16:416–420
  3. Kolibianakis E, Bourgain C, Albano C, Osmanagaoglu K, Smitz J, Van Steirteghem A, et al. Effect of ovarian stimulation with recombinant follicle-stimulating hormone, gonadotropin releasing hormone antagonists, and human chorionic gonadotropin on endometrial maturation on the day of oocyte pick-up. Fertil Steril. 2002;78:1025–1029
  4. Horcajadas JA, Díaz-Gimeno P, Pellicer A, Simón C. Uterine receptivity and the ramifications of ovarian stimulation on endometrial function. Semin Reprod Med. 2007;25:454–460
  5. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Ross R. Contrasting patterns in in vitro fertilization pregnancy rates among fresh autologous, fresh oocyte donor, and cryopreserved cycles with the use of day 5 or day 6 blastocysts may reflect differences in embryo-endometrium synchrony. Fertil Steril. 2008;89:20–26
  6. Kolibianakis EM, Bourgain C, Platteau P, Albano C, Van Steirteghem AC, Devroey P. Abnormal endometrial development occurs during the luteal phase of nonsupplemented donor cycles treated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists. Fertil Steril. 2003;80:464–466
  7. Isachenko V, Todorov P, Dimitrov Y, Isachenko E. Integrity rate of pronuclei after cryopreservation of pronuclear-zygotes as a criteria for subsequent embryo development and pregnancy. Hum Reprod. 2008;23:819–826
  8. Sills ES, McLoughlin LJ, Genton MG, Walsh DJ, Coull GD, Walsh AP. Ovarian hyperstimulation syndrome and prophylactic human embryo cryopreservation: analysis of reproductive outcome following thawed embryo transfer. J Ovarian Res. 2008;6:7
  9. Shapiro BS, Daneshmand ST, Garner FC, Aguirre A, Hudson C, Thomas S. High ongoing pregnancy rates after deferred transfer through bipronuclear oocyte cryopreservation and post-thaw extended culture. Fertil Steril, in press.
  10. Shapiro BS, Daneshmand ST, Garner FC, Aguirre A, Hudson C, Thomas S. Embryo cryopreservation rescues cycles with premature luteinization. Fertil Steril, in press.

 B.S.S. has nothing to disclose. S.T.D. has nothing to disclose. F.C.G. has nothing to disclose. M.A. has nothing to disclose. C.H. has nothing to disclose. S.T. has nothing to disclose.

PII: S0015-0282(09)01435-6

doi: 10.1016/j.fertnstert.2009.07.966

Fertility and Sterility
Volume 93, Issue 1 , Pages 319-321 , 1 January 2010

Article Tools